C-Reactive Protein (CRP) is a marker of acute phase response to inflammatory disorder. A high level of CRP in the blood is a sign that there may be an inflammatory process occurring in the body. CRP measurements have been used for many years in the management of a variety of clinical situations, such as bacterial infections, ischemic necrosis of tissue, and active inflammatory conditions. Recent studies suggest that CRP is a strong predictor of future coronary events in apparently healthy subjects and a prognostic value in patients with acute coronary syndromes.

• Two band results for simple interpretation

• Semi-quantitative analysis of human enzyme CRP

• Room temperature storage or refrigerated (2-30⁰C)

• Internal control included

• Reagents included

• Cut-off(s): See ordering information

• Sensitivity: Varies

• Specificity: Varies

• Specimen:  Whole Blood, Serum, Plasma 

• Time to Results: 10 minutes

• Shelf Life: 24 months from the date of manufacture

Sources: 1. Thomas D. Mildford-Ward A,  Whicer JT. The value of acute phase protein measurements in clinic practice. Ann. Clin Biochem; 29:123-31 (1992)

2. RIfai N. Ridker PM. High Sensitivity C reactive protein:  A Novel and Promising Marker of Coronary Hearth Disease. Clinical Chemistry 47:3 403-411( 2001)

3. Dreon DM. Slavin JL; and Phinney, SD. Oral Contraceptives increase C-Reactive Protein, an Inflammatory Biomarker by the American Physiological Society. April 9 (2003)